265 related articles for article (PubMed ID: 23228924)
1. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy.
Neilan TG; Coelho-Filho OR; Shah RV; Feng JH; Pena-Herrera D; Mandry D; Pierre-Mongeon F; Heydari B; Francis SA; Moslehi J; Kwong RY; Jerosch-Herold M
Am J Cardiol; 2013 Mar; 111(5):717-22. PubMed ID: 23228924
[TBL] [Abstract][Full Text] [Related]
2. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors.
Jordan JH; Vasu S; Morgan TM; D'Agostino RB; Meléndez GC; Hamilton CA; Arai AE; Liu S; Liu CY; Lima JA; Bluemke DA; Burke GL; Hundley WG
Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27502058
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines.
Neilan TG; Coelho-Filho OR; Pena-Herrera D; Shah RV; Jerosch-Herold M; Francis SA; Moslehi J; Kwong RY
Am J Cardiol; 2012 Dec; 110(11):1679-86. PubMed ID: 22917553
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular magnetic resonance parametric techniques to characterize myocardial effects of anthracycline therapy in adults with normal left ventricular ejection fraction: a systematic review and meta-analysis.
Musella F; Librera M; Sibilio G; Boccalatte M; Tagliamonte G; Cavaglià E; Ferrara I; Puglia M; Dell'Aversana S; Ducci CB; Dellegrottaglie S; Savarese G; Scatteia A
Curr Probl Cardiol; 2024 Jul; 49(7):102609. PubMed ID: 38697332
[TBL] [Abstract][Full Text] [Related]
5. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.
Neilan TG; Mongeon FP; Shah RV; Coelho-Filho O; Abbasi SA; Dodson JA; McMullan CJ; Heydari B; Michaud GF; John RM; Blankstein R; Jerosch-Herold M; Kwong RY
JACC Cardiovasc Imaging; 2014 Jan; 7(1):1-11. PubMed ID: 24290570
[TBL] [Abstract][Full Text] [Related]
6. Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial.
Heck SL; Gulati G; Hoffmann P; von Knobelsdorff-Brenkenhoff F; Storås TH; Ree AH; Gravdehaug B; Røsjø H; Steine K; Geisler J; Schulz-Menger J; Omland T
Eur Heart J Cardiovasc Imaging; 2018 May; 19(5):544-552. PubMed ID: 29106497
[TBL] [Abstract][Full Text] [Related]
7. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
[TBL] [Abstract][Full Text] [Related]
8. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.
Neilan TG; Coelho-Filho OR; Shah RV; Abbasi SA; Heydari B; Watanabe E; Chen Y; Mandry D; Pierre-Mongeon F; Blankstein R; Kwong RY; Jerosch-Herold M
JACC Cardiovasc Imaging; 2013 Jun; 6(6):672-83. PubMed ID: 23643283
[TBL] [Abstract][Full Text] [Related]
9. Effect of anthracycline therapy on myocardial function and markers of fibrotic remodelling in childhood cancer survivors.
Mawad W; Mertens L; Pagano JJ; Riesenkampff E; Reichert MJE; Mital S; Kantor PF; Greenberg M; Liu P; Nathan PC; Grosse-Wortmann L
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):435-442. PubMed ID: 32535624
[TBL] [Abstract][Full Text] [Related]
10. Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy.
Starc JJ; Moore RA; Rattan MS; Villa CR; Gao Z; Mazur W; Jefferies JL; Taylor MD
Pediatr Cardiol; 2017 Oct; 38(7):1485-1492. PubMed ID: 28762167
[TBL] [Abstract][Full Text] [Related]
11. Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy.
Muehlberg F; Funk S; Zange L; von Knobelsdorff-Brenkenhoff F; Blaszczyk E; Schulz A; Ghani S; Reichardt A; Reichardt P; Schulz-Menger J
ESC Heart Fail; 2018 Aug; 5(4):620-629. PubMed ID: 29673122
[TBL] [Abstract][Full Text] [Related]
12. Cardiac magnetic relaxometry versus ejection fraction in anthracycline-related cardiac changes: a systematic review and meta-analysis.
Yu C; Pathan S; Jeyaprakash P; Kritharides L; Pathan F; Negishi K
Open Heart; 2023 Jul; 10(2):. PubMed ID: 37507150
[TBL] [Abstract][Full Text] [Related]
13. [Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer].
Oberholzer K; Kunz RP; Dittrich M; Thelen M
Rofo; 2004 Sep; 176(9):1245-50. PubMed ID: 15346258
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular magnetic resonance characterisation of anthracycline cardiotoxicity in adults with normal left ventricular ejection fraction.
Harries I; Berlot B; Ffrench-Constant N; Williams M; Liang K; De Garate E; Baritussio A; Biglino G; Plana JC; Bucciarelli-Ducci C
Int J Cardiol; 2021 Nov; 343():180-186. PubMed ID: 34454967
[TBL] [Abstract][Full Text] [Related]
15. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
[TBL] [Abstract][Full Text] [Related]
16. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis.
Dusenbery SM; Jerosch-Herold M; Rickers C; Colan SD; Geva T; Newburger JW; Powell AJ
J Am Coll Cardiol; 2014 May; 63(17):1778-85. PubMed ID: 24632273
[TBL] [Abstract][Full Text] [Related]
17. Long term cardiovascular magnetic resonance phenotyping of anthracycline cardiomyopathy.
Harries I; Biglino G; Baritussio A; De Garate E; Dastidar A; Plana JC; Bucciarelli-Ducci C
Int J Cardiol; 2019 Oct; 292():248-252. PubMed ID: 31006597
[TBL] [Abstract][Full Text] [Related]
18. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
[TBL] [Abstract][Full Text] [Related]
19. T
Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
[TBL] [Abstract][Full Text] [Related]
20. Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.
Park HS; Hong YJ; Han K; Kim PK; An E; Lee JY; Park CH; Lee HJ; Hur J; Kim YJ; Choi BW
J Cardiovasc Magn Reson; 2021 Jun; 23(1):76. PubMed ID: 34134713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
